Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach
- PMID: 8275417
- DOI: 10.1002/1097-0142(19940101)73:1<15::aid-cncr2820730105>3.0.co;2-j
Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach
Abstract
Background: This study evaluated the prognosis of patients with carcinoma in the gastric remnant stump after distal gastrectomy for benign disease (stump cancer).
Methods: Twenty patients with resected stump cancer were studied and compared with 266 patients with resected primary cancer in the upper third of the stomach (primary cancer).
Results: The percentages of lymph nodes with metastases located at the lesser curvature and the left gastric artery, respectively, were 50.0% and 25.2% in patients with primary cancer and 15.0% and 5.0% in patients with stump cancer. In patients with remnant gastric cancer, lymph node metastases at jejunal mesentery near anastomotic site were found in 2 of 20 (10.0%). The 5-year survival rates were 62.1% and 52.5% for patients with curatively resected primary cancer (n = 203) and stump cancer (n = 17), respectively, and there was no statistical difference between the two groups. There was a distinct difference in terms of patterns of recurrence between patients with curatively resected primary cancer and those with stump cancer. The percentages of peritoneal and hematogenic metastases, respectively, were 40.6% and 31.3% in primary cancer and 0% and 83.3% in stump cancers.
Conclusion: The lymph flow from the remnant stomach seems to be changed by the initial operation, and as a result, in stump cancer, metastatic lymph nodes are located at different places from those associated with primary cancer. Even when curative surgery is performed in patients with stump cancer, it is important to follow up patients and check for possible metastasis to the liver.
Similar articles
-
[Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25;20(1):67-72. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 28105623 Chinese.
-
Lymph node dissection in surgical treatment for remnant stomach cancer.Hepatogastroenterology. 2002 Mar-Apr;49(44):580-4. Hepatogastroenterology. 2002. PMID: 11995502
-
Clinicopathologic characteristics and prognosis of gastric stump cancer.J Clin Gastroenterol. 1996 Dec;23(4):251-5. doi: 10.1097/00004836-199612000-00003. J Clin Gastroenterol. 1996. PMID: 8957725
-
[Stage-adapted radical principles in gastric carcinoma].Praxis (Bern 1994). 1998 Mar 25;87(13):447-50. Praxis (Bern 1994). 1998. PMID: 9584570 Review. German.
-
[Gastric stump carcinoma--a surgical and oncological challenge].Z Gastroenterol. 2011 Sep;49(9):1270-5. doi: 10.1055/s-0031-1281629. Epub 2011 Sep 1. Z Gastroenterol. 2011. PMID: 21887665 Review. German.
Cited by
-
Current status in remnant gastric cancer after distal gastrectomy.World J Gastroenterol. 2016 Feb 28;22(8):2424-33. doi: 10.3748/wjg.v22.i8.2424. World J Gastroenterol. 2016. PMID: 26937131 Free PMC article. Review.
-
Gastric cancer arising from the remnant stomach after distal gastrectomy: a review.World J Gastroenterol. 2014 Oct 14;20(38):13734-40. doi: 10.3748/wjg.v20.i38.13734. World J Gastroenterol. 2014. PMID: 25320511 Free PMC article. Review.
-
Involvement in the tumor-infiltrating CD8+ T cell expression by the initial disease of remnant gastric cancer.World J Surg Oncol. 2022 Nov 30;20(1):374. doi: 10.1186/s12957-022-02853-2. World J Surg Oncol. 2022. PMID: 36451224 Free PMC article.
-
Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association.Gastric Cancer. 2016 Apr;19(2):339-349. doi: 10.1007/s10120-015-0582-0. Epub 2015 Dec 14. Gastric Cancer. 2016. PMID: 26667370
-
Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer.Hepatol Int. 2010 Jan 29;4(1):406-13. doi: 10.1007/s12072-009-9161-y. Hepatol Int. 2010. PMID: 20305759 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical